DUBLIN--(BUSINESS WIRE)--The "Digestive Remedies in the US" report has been added to ResearchAndMarkets.com's offering.
Two years after the recall of ranitidine due to claims of increased risk of cancer, the H2 blockers category has continued to be impacted in 2022, as litigations have been in the public eye.
It is predicted that GSK, Sanofi and Pfizer could pay billions each in potential settlements, therefore increasing consumer awareness, and demand for transparency on ingredients and secondary effects. This is set to drive retail volume and current value decline in H2 blockers in 2022.
The Digestive Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Key Topics Covered:
DIGESTIVE REMEDIES IN THE US
KEY DATA FINDINGS
2022 DEVELOPMENTS
- H2 blockers continues to suffer from ranitidine recall
- Rethinking the relationship with food, and tracking changing consumer demand
- Paediatric products gain traction as dietary concerns increase
PROSPECTS AND OPPORTUNITIES
- Dulcolax leans into the popular trends of fruity products and chewable formats
- Wonderbelly looks to shake up antacids with a trendily packaged, non-GMO, and plastic-free product
Mini capsules of omeprazole to enter OTC products in the US
CATEGORY DATA
- Table 1 Sales of Digestive Remedies by Category: Value 2017-2022
- Table 2 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Digestive Remedies: % Value 2018-2022
- Table 4 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
- Table 5 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
- Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN THE US
EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
For more information about this report visit https://www.researchandmarkets.com/r/5t3ddf
